SRPT
Sarepta Therapeutics IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$1.77B
P/E Ratio
48.00
EPS
$0.35
Beta
0.26
52W High
$43.92
52W Low
$10.42
50-Day MA
$20.05
200-Day MA
$19.98
Dividend Yield
—
Profit Margin
2.98%
Forward P/E
5.46
PEG Ratio
159.25
About Sarepta Therapeutics Inc
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapies, gene therapy, and other genetic therapeutic modalities for the treatment of rare diseases. The company is headquartered in Cambridge, Massachusetts.
Fundamentals
| Revenue (TTM) | $2.18B |
| Gross Profit (TTM) | $-141.65M |
| EBITDA | $46.18M |
| Operating Margin | 49.00% |
| Return on Equity | 4.91% |
| Return on Assets | 0.02% |
| Revenue/Share (TTM) | $21.41 |
| Book Value | $14.26 |
| Price-to-Book | 1.18 |
| Price-to-Sales (TTM) | 0.81 |
| EV/Revenue | 0.988 |
| EV/EBITDA | 17.26 |
| Quarterly Earnings Growth (YoY) | 2664.00% |
| Quarterly Revenue Growth (YoY) | -1.90% |
| Shares Outstanding | $105.58M |
| Float | $94.80M |
| % Insiders | 4.09% |
| % Institutions | 98.97% |
Historical Volatility
HV 10-Day
36.19%
HV 20-Day
56.63%
HV 30-Day
49.36%
HV 60-Day
83.33%
HV Rank
—
Volatility is currently contracting
Analyst Ratings
Consensus ($22.00 target)
8
Buy12
Hold3
Sell2
Strong SellMore HEALTHCARE Stocks
Data last updated: 5/25/2026